CDRH Reopens Analyte-Specific Reagent Rule, Expanding IVD Oversight

FDA will begin expanding oversight of homebrew in vitro diagnostics with a notice of proposed rulemaking on analyte-specific reagents in the coming weeks

More from Archive

More from Medtech Insight